Precision Biosciences (DTIL) Return on Sales (2018 - 2026)
Precision Biosciences (DTIL) posted quarterly Return on Sales of 0.01% for Q1 2026, up 733.0% year-over-year from 0.0% in Q1 2025, and down 308.17% quarter-over-quarter from 0.0% in Q4 2025.
Precision Biosciences (DTIL) Return on Sales (2018 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has reported Return on Sales for 9 consecutive years, with 0.01% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Sales rose 733.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.01% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed N/A from the prior year.
- Return on Sales slipped to 0.01% in Q1 2026 per DTIL's latest filing, from 0.0% in the prior quarter.
- Across five years, Return on Sales topped out at 0.0% in Q4 2025 and bottomed at 21.27% in Q3 2025.
- Historically, Return on Sales has averaged 2.47% across 5 years, with a median of 0.01% in 2022.
- Annual changes were most pronounced in 2025 — Return on Sales tumbled 2075 bps — and 2026, when it soared 733 bps.
- Precision Biosciences' Return on Sales stood at 0.01% in 2022, then soared by 53 bps to 0.0% in 2023, then sank by 9125 bps to 0.37% in 2024, then jumped by 101 bps to 0.0% in 2025, then slumped by 308 bps to 0.01% in 2026.
- Business Quant data shows DTIL's Return on Sales at 0.01% in Q1 2026, 0.0% in Q4 2025, and 21.27% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.00% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.00% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.00% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.00% |
| 10 | Precision Biosciences | 225.21 Mn | 137.66 Mn | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.01% |
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | -21.27% |
| Jun 30, 2025 | -12.32% |
| Mar 31, 2025 | -7.34% |
| Dec 31, 2024 | -0.37% |
| Sep 30, 2024 | -0.51% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.09% |
| Mar 31, 2022 | -0.10% |
| Dec 31, 2021 | -0.05% |
| Sep 30, 2021 | -0.01% |